Showing results (131-140 of 215) with videos related to
Sort By:
Pageof 22
Diagnostics (Basel, Switzerland)|September 28, 2021
C-Reactive Protein for the Early Assessment of Non-Malarial Febrile Patients: A Retrospective Diagnostic StudyGiulia Bertoli, Cristina Mazzi, Niccolò Ronzoni, et al.Malaria Journal|September 8, 2007
World Antimalarial Resistance Network (WARN) IV: clinical pharmacologyKaren I Barnes, Niklas Lindegardh, Olumide Ogundahunsi, et al.Scientific Reports|July 16, 2024
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methodsMunib Mesinovic, Xin Ci Wong, Giri Shan Rajahram, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|July 2, 2004
Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trialGerardo Priotto, Jerome Kabakyenga, Loretxu Pinoges, et al.Reproductive Toxicology (Elmsford, N.Y.)|September 9, 2006
In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryosMonica Longo, Sara Zanoncelli, Paola Della Torre, et al.The American Journal of Tropical Medicine and Hygiene|October 10, 2018
Hymenolepis nana-An Emerging Intestinal Parasite Associated with Anemia in School Children from the Bolivian ChacoMichele Spinicci, Fabio Macchioni, Simona Gabrielli, et al.Parasitology|August 30, 2013
Open source drug discovery - a limited tutorialMurray N Robertson, Paul M Ylioja, Alice E Williamson, et al.Plos Neglected Tropical Diseases|February 21, 2024
Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile developmentMaría Del Mar Castro, Astrid C Erber, Byron Arana, et al.Plos Neglected Tropical Diseases|November 8, 2012
Fexinidazole: a potential new drug candidate for Chagas diseaseMaria Terezinha Bahia, Isabel Mayer de Andrade, Tassiane Assíria Fontes Martins, et al.Journal of Pharmaceutical and Biomedical Analysis|May 15, 2012
Development of NIRS method for quality control of drug combination artesunate-azithromycin for the treatment of severe malariaChantal Boyer, Karen Gaudin, Tina Kauss, et al.Pageof 22